[Urine markers with special regard to fluorescent in situ hybridization (FISH)].
Patient care with noninvasive or minimally invasive methods is appealing for the patient. It has to be assessed in terms of validity to guarantee improvement of patient care. Urine cytology for the detection of tumour cells can be considered a valid method since its specificity and sensitivity is high when high-grade tumour cells are sought. High-grade tumour cells are considered the clinically most relevant finding in urine specimens. Fluorescent in situ hybridization of interphase nuclei on centromeric and gene loci has been optimized for urothelial carcinoma and increases the sensitivity of tumour findings. It also gives a valid chance to adapt the number of cystoscopies in the follow-up of bladder cancer patients more individually.
Institut für Pathologie, RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Deutschland.
K
K
Lindemann-Docter
N T
NT
Gaisa
D
D
Smeets
R
R
Knüchel-Clarke
D014408:Biomarkers, Tumor / Q000652:urine*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D009363:Neoplasm Proteins / Q000652:urine*; D016482:Urinalysis / Q000379:methods*; D001749:Urinary Bladder Neoplasms / Q000473:pathology* / Q000652:urine*
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins
J Urol. 2006 Jul;176(1):44-7
16753364
BJU Int. 2010 Aug;106(3):349-54
20089114
Int J Biol Markers. 2008 Oct-Dec;23(4):249-61
19199274
Ann Oncol. 2010 Apr;21(4):815-819
19889613
Urologe A. 2009 Jun;48(6):598-608
19557464
Am J Clin Pathol. 2010 Oct;134(4):597-603
20855641
J Clin Pathol. 2008 Mar;61(3):272-7
17693577
Eur Urol. 2010 Aug;58(2):288-92
20471154
Pathologe. 2009 Dec;30 Suppl 2:173-8
19820939
Cancer. 2009 Sep 15;115(18):4090-5
19536901